603392: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. - Summary | Jitta

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

CHN:603392

Price
CN¥47.95
Loss Chance
43.2%
6.42JITTA SCORE
6.11%Under Jitta Line
Jitta Ranking
271 / 481
2,691 / 5,108
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (55)
Recent Business Performance (22)
Financial Strength (88)
Return to Shareholders (72)
Competitive Advantage (66)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Operating MarginConsistent
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
SG&A to SalesDecreasing
Recent IPOLess than 3 years
Recent Business PerformanceEarning decline 88.05% in the last quarter (yoy)
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
6.42
6.11%
4.00
937.42%
4.70
740.99%
Biotechnology
6.85
49.28%
6.07
455.21%
7.63
23.30%
COMPANY DESCRIPTION
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.